Drugs / Allogeneic Microbiota in Glycerol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05780801 | Apr 2023 → Jan 2024 | — | Emory University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Microbiota in Glycerol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05780801 ↗ |
| Known as | AMG | “Live microbiome therapeutic prepared as Allogeneic Microbiota in Glycerol (10%) (AMG)” NCT05780801 ↗ |
| Route | Other | “delivered through an already existing feeding tube” NCT05780801 ↗ |